Extent and Resistance Patterns of Gram-negative Bacteria Isolated From 13 Hospitals in Shaoxing, Zhejiang Province.

IF 1.5 4区 医学 Q4 MICROBIOLOGY New Microbiologica Pub Date : 2024-01-01
Yiqing Zhou, Meichun Liang, Xiaojiao Zhang, Qiuli He, Li Lv, Guofeng Mao
{"title":"Extent and Resistance Patterns of Gram-negative Bacteria Isolated From 13 Hospitals in Shaoxing, Zhejiang Province.","authors":"Yiqing Zhou, Meichun Liang, Xiaojiao Zhang, Qiuli He, Li Lv, Guofeng Mao","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Gram-negative bacteria are increasingly recognized as the sauce of severe infections. In recent years, epidemiological data has indicated that the drug resistance rate of Gram-negative bacteria has significantly increased. We analyzed the epidemiological surveillance data of gram-negative bacteria in Shaoxing City in 2021 by retrospectively collecting drug susceptibility data of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Burkholderia cepacian from thirteen tertiary hospitals. A total of 24,142 strains were collected from thirteen hospitals. The isolation rates of E. coli, K. pneumoniae, P. aeruginosa, A. baumannii, P. mirabilis, E. cloacae, and B. cepacian were 29.25%, 18.83%, 11.03%, 8.43%, 3.80%, 3.12%, and 0.75%, respectively. Among them, 2.86% were carbapenem-resistant E. coli, 12.98% were CRKP, 31.27% were CRPA, and 34.77% were CRAB. Carbapenem-resistant Enterobacterales were more sensitive to ceftazidime-avibactam and polymyxin. The drug resistance rates of P. aeruginosa and A. baumannii to polymyxin were 0 and 1.3%, but the resistance rates to ceftazidime-avibactam were 10.5% and 26.0%, respectively. Based on results from epidemiological data, CRKP had a high isolation rate and non-fermenting bacteria had a high resistance rate to ceftazidime-avibactam. All hospitals should strengthen monitoring and enact continuous intervention to reduce the generation and spread of drug-resistant bacteria.</p>","PeriodicalId":54723,"journal":{"name":"New Microbiologica","volume":"46 4","pages":"340-347"},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Microbiologica","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gram-negative bacteria are increasingly recognized as the sauce of severe infections. In recent years, epidemiological data has indicated that the drug resistance rate of Gram-negative bacteria has significantly increased. We analyzed the epidemiological surveillance data of gram-negative bacteria in Shaoxing City in 2021 by retrospectively collecting drug susceptibility data of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Burkholderia cepacian from thirteen tertiary hospitals. A total of 24,142 strains were collected from thirteen hospitals. The isolation rates of E. coli, K. pneumoniae, P. aeruginosa, A. baumannii, P. mirabilis, E. cloacae, and B. cepacian were 29.25%, 18.83%, 11.03%, 8.43%, 3.80%, 3.12%, and 0.75%, respectively. Among them, 2.86% were carbapenem-resistant E. coli, 12.98% were CRKP, 31.27% were CRPA, and 34.77% were CRAB. Carbapenem-resistant Enterobacterales were more sensitive to ceftazidime-avibactam and polymyxin. The drug resistance rates of P. aeruginosa and A. baumannii to polymyxin were 0 and 1.3%, but the resistance rates to ceftazidime-avibactam were 10.5% and 26.0%, respectively. Based on results from epidemiological data, CRKP had a high isolation rate and non-fermenting bacteria had a high resistance rate to ceftazidime-avibactam. All hospitals should strengthen monitoring and enact continuous intervention to reduce the generation and spread of drug-resistant bacteria.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从浙江省绍兴市 13 家医院分离的革兰氏阴性菌的分布范围和耐药性模式。
人们越来越认识到,革兰氏阴性细菌是造成严重感染的罪魁祸首。近年来,流行病学数据表明,革兰氏阴性菌耐药率明显上升。我们分析了 2021 年绍兴市革兰氏阴性菌的流行病学监测数据,回顾性收集了 13 家三级医院的大肠埃希菌、肺炎克雷伯菌、奇异变形杆菌、泄殖腔肠杆菌、铜绿假单胞菌、鲍曼不动杆菌和头孢伯克霍尔德菌的药敏数据。十三家医院共收集到 24 142 株菌株。大肠杆菌、肺炎双球菌、绿脓杆菌、鲍曼不动杆菌、奇异变形杆菌、泄殖腔大肠杆菌和头孢杆菌的分离率分别为 29.25%、18.83%、11.03%、8.43%、3.80%、3.12% 和 0.75%。其中,耐碳青霉烯类大肠杆菌占 2.86%,CRKP 占 12.98%,CRPA 占 31.27%,CRAB 占 34.77%。耐碳青霉烯类肠杆菌对头孢他啶-阿维巴坦和多粘菌素更敏感。铜绿假单胞菌和鲍曼不动杆菌对多粘菌素的耐药率分别为 0% 和 1.3%,但对头孢他啶-阿维巴坦的耐药率分别为 10.5% 和 26.0%。根据流行病学数据结果,CRKP 的分离率较高,非发酵菌对头孢他啶-阿维巴坦的耐药率也较高。所有医院都应加强监测和持续干预,以减少耐药菌的产生和传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
New Microbiologica
New Microbiologica 生物-微生物学
CiteScore
2.20
自引率
5.60%
发文量
40
审稿时长
6-12 weeks
期刊介绍: The publication, diffusion and furtherance of research and study on all aspects of basic and clinical Microbiology and related fields are the chief aims of the journal.
期刊最新文献
Analysis of infection indicators and risk factors for influenza A after the COVID-19 pandemic. Clinical Pharmacology of the Single Tablet Regimen Bictegravir/Emtricitabine/Tenofovir Alafenamide in the evolving era of antiretroviral therapies. Comparison between rapid and laboratory serological tests in the context of the first responders during the SARS-CoV-2 outbreak: are the two tests interchangeable? Critical insights into the ocular surface microbiome: the need to standardize. Epidemiological characteristics and related risk factors of mixed infection in children with mycoplasma pneumoniae pneumonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1